Momenta, Sandoz Can't Beat Blood Clot Drug Monopoly Suit
A Tennessee federal magistrate judge on Thursday recommended that a proposed class action accusing Momenta Pharmaceuticals Inc. and Sandoz Inc. of conspiring to monopolize the market for a generic of the...To view the full article, register now.
Already a subscriber? Click here to view full article